AD1330103-S8289532 (Collection)

Id Namespace:

GlyGen Project

Identifier Namespace (Entity type)

Dcc Asset:

glygen cfde 2025 sept data submission.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Description:Collection for all glycans on slide S8289532 in dataset AD1330103

Creation Time:2025-09-03T20:18:09-04:00

Results found

Linked to

	Label	Description
	N-ACETYL-beta-D-GLUCOSAMINE Compound (Entity type)	A Compound
	2-acetamido-2-deoxy-alpha-D-galactopyranose Compound (Entity type)	A Compound
	alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->6)]-alpha-D-mannosyl-(1->6)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine Compound (Entity type)	A Compound
	Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4(Fucalpha1-6)GlcNAcbeta Compound (Entity type)	A Compound
	alpha-D-Manp-(1->2)-alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Compound (Entity type)	A Compound
	Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta Compound (Entity type)	A Compound
	Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4GlcNAc Compound (Entity type)	A Compound
	T-disaccharide Compound (Entity type)	A Compound
	alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc Compound (Entity type)	A Compound
	alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc Compound (Entity type)	A Compound

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

A Compound

2-acetamido-2-deoxy-alpha-D-galactopyranose

Compound (Entity type)

A Compound

alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->6)]-alpha-D-mannosyl-(1->6)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Compound (Entity type)

A Compound

Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4(Fucalpha1-6)GlcNAcbeta

Compound (Entity type)

A Compound

alpha-D-Manp-(1->2)-alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc

Compound (Entity type)

A Compound

Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta

Compound (Entity type)

A Compound

Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4GlcNAc

Compound (Entity type)

A Compound

T-disaccharide

Compound (Entity type)

A Compound

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

Compound (Entity type)

A Compound

alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc

Compound (Entity type)

A Compound

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.